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Abstract
Depression is estimated to affect more than 6.5 million Americans 65 years of age and older and compared with non-Latino whites older U.S. 
Latinos have a greater incidence and severity of depression, warranting further investigation of novel risk factors for depression onset among 
this population. We used data on 771/1,789 individuals ≥60 years of age from the Sacramento Area Latino Study on Aging (1998–2008) who 
were tested for cytomegalovirus (CMV), herpes simplex virus, varicella zoster, Helicobacter pylori, Toxoplasma gondii, and C-reactive protein 
(CRP) and interleukin-6 (IL-6) level. Among those without elevated depressive symptoms at baseline, we examined the association between 
each pathogen, inflammatory markers and incident depression over up to nearly 10 years of follow-up using discrete-time logistic regression. 
We found that only CMV seropositivity was statistically significantly associated with increased odds of incident depression (odds ratio [OR]: 
1.38, 95% confidence interval [CI]: 1.00–1.90) in the total sample as well as among women only (OR: 1.70, 95% CI: 1.01–2.86). These 
associations were not mediated by CRP or IL-6 levels. Our findings suggest that CMV seropositivity may serve as an important risk factor for 
the onset of depression among older U.S. Latinos, but act outside of inflammatory pathways.
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Depression affects approximately 6.5 million Americans 65 years 
of age and older and is estimated to be the leading cause of disabil-
ity worldwide by 2030 (1). Although compared with non-Latino 
whites and blacks, younger U.S. Latinos have similar or even lower 
prevalence of major depression (2), this pattern has been shown 
to reverse in older age (3). Moreover, U.S. Latinos who become 
depressed also experience more severe and more chronic depres-
sive symptoms over time (3). Given the U.S. population is rapidly 
aging and the number of Latinos over the age of 60 is projected to 
increase at a rate almost three times as fast as non-Latino whites 
over the next several decades (4), it remains important to identify 
novel risk factors for depression onset among older U.S. Latinos, 
to both reduce the overall burden of depression as well as prevent 
the development of race/ethnic disparities in mental health in the 
United States in the coming years.
Age-related declines in immune function that increase susceptibil-
ity to novel infections and/or impair immunologic control of latent 
infections are well-documented (5), and a growing body of evidence 
has suggested that infection-mediated immune alterations, such as 
inflammation, may play a key role in the regulation of mood (6). 
For example, proinflammatory cytokines which may be triggered in 
response to infection have been hypothesized to alter serotonin pro-
duction and glutamatergic neurotransmission via enhancing trypto-
phan metabolism (6). Pathogens which once acquired persist over 
time, such as herpesviruses, have been suggested to be particularly 
relevant to the onset of mood disorders in older individuals as such 
infections are subject to reactivation with age-related declines in cell-
mediated immune processes (7–9). Helicobacter pylori, a gram-nega-
tive bacteria which establishes chronic infection within the stomach 
has also been hypothesized to influence mood regulation via interac-
tions at the “gut-brain” axis (10) and the persistent neurotropic path-
ogen, Toxoplasma gondii via directly invading and altering levels of 
dopamine and serotonin within the brain (11). Helicobacter pylori 
and T gondii have, however, been examined in relation to depres-
sion primarily among younger individuals (12–15). The majority 
of previous studies examining the association between persistent 
pathogens and depression have, moreover, been cross-sectional 
(7–9,14,15) and have yielded mixed findings (15–21) regarding the 
role of inflammation as a biologic mediator of these pathways. For 
these reasons, questions remain regarding the role of persistent path-
ogens in increasing risk for onset of depression in older individuals 
via inflammatory pathways. Several studies have demonstrated that 
U.S. Latinos are more likely to be seropositive for several persistent 
pathogens compared with non-Latino whites (22–24), thus assess-
ment of the relationship between persistent pathogens and depres-
sion among this population subgroup is further warranted.
A parallel body of literature has demonstrated that women have 
a greater burden of depression prevalence and severity (25) and dif-
ferences in inflammatory response between women and men has 
been hypothesized to play a key role in explaining such observations 
(26). A recent study of young- to middle-aged U.S. adults identified 
positive associations between pathogens including cytomegalovirus 
(CMV) and H pylori on mood disorders in women but a protect-
ive effect among men (15). The associations among women were
not mediated, however, by levels of the proinflammatory cytokine,
C-reactive protein (CRP) (15). Although some evidence suggests that 
there are differences in the effect of T gondii on behavioral changes
between women and men (27), findings from studies examining the
association between T gondii and depression among women separ-
ately have been mixed (12,13,28) and not assessed the role of inflam-
matory pathways. Overall, further investigation into whether there
are differences in the association between a broad array of persistent 
pathogens and depression between women and men over time in
older age and the role of inflammation as a relevant mediator of
these associations is warranted.
The proposed study utilizes data from a subset of individuals 
in the Sacramento Area Latino Study on Aging (SALSA), a longitu-
dinal study of nearly 1,800 elderly Mexican Americans who were 
tested for seropositivity and immunoglobulin G (IgG) antibody lev-
els for five persistent pathogens (CMV, herpes simplex virus-1 (HSV-
1), varicella zoster (VZV), T gondii and H pylori) and assessed for 
depressive symptoms over up to six follow-up visits spanning more 
than 9 years of follow-up. The objectives of this study are to exam-
ine whether (a) seropositivity for and/or IgG antibody level targeted 
against persistent pathogens are associated with incident depression, 
(b) whether elevated levels of the proinflammatory cytokines CRP
and interleukin-6 (IL-6) at baseline partially mediate these associa-
tions, and (c) whether sex/gender is a modifier of these relationships.
Methods
Study Population
Beginning in 1998–1999, 1,789 elderly male and female Latino 
(95% of Mexican origin) individuals between 60 and 101 years of 
age, residing in the Sacramento Valley of California were recruited 
into the SALSA cohort and underwent a baseline in-home interview 
and medical exam, during which a trained bilingual health techni-
cian collected data on sociodemographics, medical history, medica-
tion usage, behavioral risk factors, cognitive and functional status, 
and depressive symptoms. In-home interviews were repeated at 
12- to 15-month intervals, during which information on depres-
sive symptoms as well as other sociodemographic and behavioral
characteristics of interest were obtained. We restricted our analyses
to 1,208 (70.1%) individuals who were free of elevated depres-
sive symptoms and not taking anti-depressant medications at base-
line. Among these individuals, 119 (9.9%) were missing data on
baseline characteristics of interest including age, gender, nativity,
acculturation score, annual household income level, education
level, smoking status, alcohol consumption, or body mass index
(BMI) kg/m2 and excluded from all analyses. Of the remaining
1,089 individuals, 846 (77.7%) also had serum samples collected
and tested for IgG antibodies targeted against CMV, HSV-1, VZV,
T gondii, and H pylori as well as the proinflammatory cytokines
IL-6 and CRP at baseline. Individuals with serum samples were
significantly younger and more likely to be female compared with
those without samples. Of these individuals, 75 (8.9%) individuals
were lost to follow-up as of the first follow-up visit and excluded
from longitudinal analyses. Individuals who were lost to follow-up
as of the first visit were more likely to have lower education and
income level compared with those not lost to follow-up. Among
those included in our analytic sample (N = 771), loss to follow-up
was 6.4%, 6.4%, 10.0%, 8.9%, and 10.5% in follow-up visits 2–6, 
respectively.
Approximately 26% of individuals included in our subsample 
were missing data on depressive symptoms or medication use during 
one or more home interviews between the baseline interview and 
loss to follow-up. We performed multiple imputation via the chained 
equations (MICE) package in R. MICE runs a series of regression 
models in which a missing variable is regressed on all other available 
variables, and then prediction models are used to impute missing val-
ues for that specific variable. Using this method, we imputed missing 
values for depressive symptoms or medication use at any interview 
preceding loss to follow-up via carrying out linear or logistic regres-
sion and then predictive mean matching or logistic regression pre-
diction, respectively. We then averaged the estimates for the log odds 
ratio for depression yielded from 40 imputed data sets to obtain a 
final estimate for each association of interest. The estimated covari-
ance incorporating within and between imputation variability was 
computed based upon methods by Rubin and Schenker (29).
The Sacramento Area Latino Study on Aging (SALSA) was 
approved by the Institutional Review Boards at the University of 
Michigan and the University of California at San Francisco and 
Davis.
Laboratory Analyses
Frozen (−80°C) serum samples were sent to the Stanley Laboratory 
of Developmental Neurovirology at Johns Hopkins University 
School of Medicine and tested for presence of IgG antibody levels 
to CMV, HSV-1, VZV, H pylori, and T gondii using a solid-phase 
enzyme-linked immunosorbent assays (ELISA) as described previ-
ously (30,31). Briefly, diluted aliquots of serum were reacted with 
antigen bound to a solid-phase surface. Quantification of IgG anti-
body levels for each pathogen was determined by reaction of bound 
antibodies with enzyme labeled anti-human IgG (30). Continuous 
IgG antibody levels were measured via optical density unit (ODU) 
values and individuals with ODU values <1.1 were categorized as 
seronegative and those with ODU values ≥1.1 as seropositive for 
CMV, HSV-1, VZV, and H pylori. Continuous IgG levels for T gondii 
were assessed in international units (IU)/mL and the cut-point for 
seropositivity to T gondii was ≥10 IU/mL.
Baseline frozen (−70°C) serum samples were also analyzed for 
IL-6, and high-sensitivity CRP levels. IL-6 levels were determined 
by using the Quantiglo Chemiluminescent Immunoassay, QTA00B 
and Q6000B, respectively (R&D Systems, Minneapolis, MN). CRP 
protein levels were assayed with the CRP Ultra Wide Range Reagent 
Kit latex-enhanced immunoassay (Equal Diagnostics, Exton, PA).
Outcome
Depressive symptoms were assessed at baseline and each follow-
up visit via the Center for Epidemiological Studies Depression 
Scale (CESD) (32), a 20-item screening questionnaire that has been 
widely used in Latino populations of all ages and levels of accul-
turation (33). Depressive symptoms scores range from 0 to 60 and 
scores of ≥16 are considered consistent with clinical depression (32). 
Individuals with CESD scores of ≥16 or whom were taking anti-
depressant medications at baseline were categorized as depressed 
and excluded from longitudinal analyses. Individuals not excluded 
at baseline that reported elevated depressive symptoms (ie, CESD 
score of ≥16) or new use of anti-depressant medications at each sub-
sequent follow-up interview were categorized as an incident case of 
depression as has been done in previous studies (34).
Covariates
Several characteristics were considered as potential confounders in 
our analyses as they have been associated with seropositivity or IgG 
antibody response to persistent pathogens as well as identified as risk 
factors for depression including age, gender, nativity, education level, 
income level, acculturation status, BMI, smoking status, alcohol use, 
and non-steroidal anti-inflammatory drug (NSAID) use (for analy-
ses with proinflammatory cytokines only) in previous studies. Age in 
years at baseline was calculated from date of birth and was treated 
as continuous. Gender was self-reported, and individuals were cat-
egorized as male or female. Individuals self-reported the income level 
that best represented their total household income in the past month 
at baseline without deductions (<$1,000, $1,000–1,499, $1,500–
1,999, $2,000–2,499, or $2,500 and more). State and country of 
birth was self-reported, and individuals were categorized as Mexican 
born, U.S. born or other. Marital status was self-reported as never 
married, married, widowed, divorced, separated, or living with 
someone as married. Acculturation status was measured at base-
line with the Acculturation Rating Scale (ARSMA-II), an established 
measure of cultural orientation that assesses the dynamic accultur-
ative process comprehensively along multiple dimensions, including 
those related to ethnic identity and co-ethnic social ties (35). Lower 
scores represent stronger Mexican orientation, whereas higher 
scores represent stronger Anglo orientation. Continuous scores were 
categorized into tertiles representing Mexican orientation (lowest 
tertile), bicultural orientation (middle tertile), and Anglo orienta-
tion (highest tertile). BMI (kg/m2) was calculated from height and 
weight assessed at baseline and treated as continuous. Individuals 
also reported whether they were current, former, or never smokers 
and were categorized as ever or never smokers at baseline. Alcohol 
consumption was ascertained at baseline and individuals were cat-
egorized according to whether they currently drink wine, beer, and/
or alcohol (yes vs no). Medication use was ascertained via a medi-
cine cabinet inventory at baseline as well as each follow-up home 
visit and medications were classified according to the National 
Drug Coding Directory. Individuals were categorized according to 
whether they were currently taking anti-depressants or NSAIDs at 
baseline and each follow-up home visit (yes vs no).
Statistical Analyses
Statistical analyses were carried out using R3.1.1. We first estimated 
descriptive statistics (ie, mean [±standard deviation (SD)] for all 
continuous variables and proportion for all categorical variables) 
among individuals who were tested for pathogen seropositivity, free 
of depression at baseline, not missing data on any other covariates 
of interest and had data on depression collected during at least one 
follow-up visit (N= 771). Discrete-time logistic regression models 
were used to examine the association between pathogen seroposi-
tivity/IgG antibody level as well as IL-6 and CRP levels and inci-
dent depression among those free of depression at baseline (ie, CESD 
score <16 and no medication use). Models were first unadjusted, then 
adjusted for sociodemographic characteristics including age, gender, 
education level or income level, nativity, level of acculturation and 
marital status, and last for clinical characteristics including BMI (kg/
m2), smoking status, and alcohol use. Models examining the associ-
ation between IL-6 and CRP levels at baseline and incident depres-
sion were additionally adjusted for NSAID use at baseline. To assess 
the mediating role of IL-6 and CRP levels in the pathway between 
pathogen seropositivity and IgG antibody level and incident depres-
sion we decomposed the total effect of pathogen serostatus or IgG 
level on incident depression into direct and indirect effects (ie, effect 
mediated via IL-6 or CRP level). The direct effect is the association 
between pathogen serostatus/IgG level and incident depression after 
adjustment for IL-6 or CRP level and the indirect effect is calculated 
as the difference between total effect (ie, association between patho-
gen serostatus/IgG level and incident depression without adjustment 
for IL-6 or CRP level) and the direct effect. Bootstrapping was used 
to compute the standard error and corresponding p-value for the 
indirect effect. We also repeated all analyses stratified by gender and 
also ran models including an interaction term between gender and 
the exposure (ie, pathogen seropositivity/IgG level or proinflamma-
tory marker level).
Results
Demographic and clinical characteristics of the sample at baseline 
are shown in Table 1. The mean age of individuals at baseline was 
69.4 (±6.2) years, 54.5% were female, 38.5% had a 12 or more 
years of education, and the majority of individuals (35.7%) had 
a household income level in the past month of <$1000. A total of 
39.3% of individuals were Mexican-born, and the majority (62.8%) 
were married or living with someone as a spouse. The mean BMI 
(kg/m2) of individuals at baseline was 29.9 (±5.8), 10.1% were 
current smokers, 59.4% consumed alcohol, 13.2% of individuals 
were currently taking NSAIDS, and the mean CESD score at base-
line was 4.6 (±4.5). At baseline, 86.4%, 83.5%, 30.1%, 90.5%, and 
37.1% were seropositive for HSV-1, CMV, VZV, H pylori, and T 
gondii, respectively and the mean (±SD) IgG antibody level for these 
pathogens were 2.4 (±1.2) ODU, 1.0 (±0.5) ODU, 2.1 (±1.0) ODU, 
3.7 (±1.9) ODU, and 13.1 (±13.1) IU/mL, respectively. The mean 
log IL-6 and CRP values among individuals in the sample were 1.3 
(±0.7) and 1.1 (±1.1), respectively. Over the mean 6.4 years of fol-
low-up (range 0.8–9.4), a total of 336 (43.5%) individuals became 
an incident case of depression.
The longitudinal association between pathogen seropositivity, 
IgG antibody level, and inflammatory marker levels at baseline and 
incident depression are shown in Table 2. In the total sample, indi-
viduals that were CMV seropositive at baseline had 1.38 (95% CI: 
1.00–1.90; p = .0498) times the odds incident depression compared 
to those that were seronegative, in the fully adjusted model. Although 
there was a positive association between HSV-1 as well as H pylori 
seropositivity and incident depression, these associations were not 
statistically significant, and there were no associations between IgG 
antibody level for any pathogen and incident depression (Table 2). 
In the unadjusted models, for every 1 SD increase in log IL-6 level 
at baseline, the odds of incident depression increased by 16% (OR: 
1.16, 95% CI: 1.05–1.28), however this association was not statis-
tically significant in the fully adjusted model (OR: 1.09, 95% CI: 
0.98–1.22). The association between CMV seropositivity and inci-
dent depression among the total sample was only slightly attenuated 
after control for log IL-6 or CRP but became marginally statistically 
significant (OR: 1.36, 95% CI: 0.98–1.88, p = .067 and OR: 1.38, 
95% CI: 1.00–1.90, p = .0502, respectively). The indirect effects of 
CMV seropositivity and depression through IL-6 and CRP were not 
statistically significant (OR: 1.02, 95% CI: 0.98–1.04, p = .55 and 
OR: 1.00, 95% CI: 0.99–1.01, p = .86, respectively).
In stratified analyses, the association between CMV seropositiv-
ity and incident depression was only statistically significant among 
women (OR: 1.70, 95% CI: 1.01–2.86)  and stronger compared 
to men (OR: 1.29, 95% CI: 0.96–1.73; p-value for interaction 
term  =  .3600) in fully adjusted models. There were, however, no 
statistically significant associations between seropositivity for any 
other pathogens or IgG antibody level for any pathogen and incident 
depression among women or men, nor any statistically significant 
interactions between pathogen seropositivity or IgG antibody level 
and gender (Supplementary Table 1). Among women, neither log IL-6 
or log CRP level at baseline was statistically significantly associated 
with incident depression in fully adjusted models (Supplementary 
Table  1). While the association between CMV seropositivity and 
incident depression among women was slightly attenuated (HR: 
1.65, 95% CI: 0.97–2.80) and no longer statistically significant after 
additional adjustment for log IL-6 level, the association was similar 
in magnitude and remained statistically significant after adjustment 
for log CRP level (HR: 1.71, 95%: 1.01–2.86). Moreover, the indirect 
effects through IL-6 and CRP were not statistically significant (HR: 
1.03, 95%: 0.96–1.10 and HR: 0.99, 95% CI: 0.94–1.05, respec-
tively). Among men, however, the association between log IL-6 and 
depression among men (OR: 1.11, 95% CI: 1.00–1.23), remained 
statistically significant after covariate adjustment (Supplementary 
Table  2). Given there were no statistically significant associations 
for pathogen seropositivity/IgG level and incident depression among 
men, we did not further test for mediation by log IL-6 or CRP level. 
There were no statistically significant interactions between inflam-
matory markers and gender.
Discussion
To our knowledge, this is the first study to examine the longitudi-
nal association between numerous persistent pathogens and incident 
depression over up to nearly a decade of follow-up among older indi-
viduals, and moreover, to assess the mediating role of IL-6 and CRP 
level in these associations. CMV was the only pathogen for which 
seropositivity was statistically significantly associated with incident 
depression in the total sample. In stratified analyses, the association 
between CMV was, moreover, stronger and only statistically signifi-
cant among women. There were, however, no statistically significant 
interactions between pathogen seropositivity or IgG antibody and 
gender. We also did not find evidence for mediation of the associa-
tions for CMV seropositivity and incident depression observed in 
Table 1. Study Sample Demographic and Clinical Characteristics 
of Individuals from the Sacramento Area Latino Study on Aging
Characteristic N= 771
Age (years), mean (± SD) 69.4 (± 6.2)
Gender, N (%)
 Male 351 (45.5)
 Female 420 (54.5)
Education (years), N (%)
0-11 474 (61.5)
12+ 297 (38.5)
Household income level (past month), N (%)
< $1000 275 (35.7)
 $1000-1499 146 (18.9)
 $1500-1999 96 (12.4)
 $2000-2499 106 (13.8)
≥ $2500 148 (19.2)
Acculturation, N (%)
 Mexican-oriented 209 (27.1)
 Bicultural 262 (34.0)
 Anglo-oriented 300 (38.9)
Nativity Status, N (%)
Mexican born 303 (39.3)
US born 428 (55.5)
 Other 40 (5.2)
Marital Status, N (%)
Single/Never Married 21 (2.7)
Married/Living With Someone as Spouse 484 (62.8)
 Widowed 166 (21.5)
 Divorced/Separated 100 (13.0)
Body mass index (kg/m2), mean (± SD) 29.9 (± 5.8)
Smoking Status, N (%)
 Never 362 (47.0)
 Former 331 (42.9)
 Current 78 (10.1)
Alcohol Consumption, N (%)
 No 313 (40.6)
 Yes 458 (59.4)
CESD score, mean ( ± SD) 4.6 (± 4.5)
Non-steroidal anti-inflammatory drug use
 No 669 (86.8)
 Yes 102 (13.2)
Pathogen Seropositivity, N (%)
Herpes simplex virus-1 666 (86.4)
 Cytomegalovirus 644 (83.5)
Varicella zoster virus 232 (30.1)
Helicobacter pylori 698 (90.5)
Toxoplasma gondii 286 (37.1)
Pathogen IgG antibody level, mean (± SD)a
Herpes simplex virus-1 2.4 (± 1.3)
 Cytomegalovirus 1.0 (± 0.5)
Varicella zoster virus 2.1 (± 1.0)
Helicobacter pylori 3.7 (±1.9)
Toxoplasma gondii 13.1 (± 13.1)
Log interleukin-6 level, mean (± SD) 1.3 (± 0.7)
Log C-reactive protein level, mean (± SD) 1.1 (± 1.1)
Note. IgG; immunoglobulin G.
aImmunoglobulin G antibody levels measured in international units for 
Toxoplasma gondii and in optical density units for all other pathogens
the total sample or among women by inflammatory markers. Our 
findings suggest that CMV seropositivity may be an important risk 
factor for onset of depression in older age among U.S. Latinos and 
moreover, that this pathogen may act through physiologic pathways 
outside of inflammation.
Previous studies have consistently identified an association 
between CMV and depression among middle-aged and older indi-
viduals, but findings for seropositivity versus IgG antibody level 
have been mixed (7,8,16,36). For example, Miller and colleagues 
(9) observed that older individuals (mean age: 61)  in the highest
tertile of depressive symptoms were more likely to be seropositive
for CMV among a clinical cohort of individuals recovering from
acute coronary syndrome, but did not assess IgG antibody level. In
another cross-sectional study of older individuals (mean age: 73.6),
Phillips and colleagues (7) identified that for every one unit increase
in CMV IgG antibody level, odds of depression was 1.18 (95% CI:
1.04–1.33) times higher, but found no association for CMV sero-
positivity. Similarly, several cross-sectional studies conducted among
middle-aged individuals found higher CMV IgG antibody level, but
not CMV seropositivity, was associated with elevated depressive
symptoms (36,37). We are only aware of one other longitudinal
study that examined the association between CMV seropositivity as
well as IgG antibody level and incident depression (16). In contrast
to the present study, the authors found among a community-based
sample of middle-aged (mean age: 54.0 ± 15.8 years) no association
between CMV seropositivity and incident depression over approxi-
mately 1 year of follow-up but that CMV seropositive individuals
with IgG antibody levels in the highest quartile at baseline had over
three times the odds of incident depression during this period (16). It 
is possible that CMV seropositivity is a stronger predictor of depres-
sion onset in older individuals than small differences in IgG antibody 
level targeted against this pathogen in the context of overall age-
related declines in antibody production.
Fewer studies have examined the association between HSV-1 
and depression and have also reported conflicting findings (9,15,16). 
Although Miller and colleagues (9) observed that older individuals 
in the highest tertile of depressive symptoms were more likely to be 
seropositive HSV-1, Simanek and colleagues (16) found no associa-
tion between HSV-1 seropositivity or IgG antibody level and inci-
dent depression in the Detroit Neighborhood Health Study (DNHS), 
nor among younger U.S. adults using data from the National Health 
and Nutrition Examination Survey (NHANES) III (15). Although 
some studies have found that older individuals with depression have 
lower markers of VZV-specific cell-mediated immunity, compared 
with controls (38), our findings of no association between VZV and 
depression are consistent with a previous study by Irwin and col-
leagues (39), in which the authors found no association between 
VZV antibody levels and depression. In another study by Chen and 
colleagues (40), the authors found that individuals ≥18 years of age 
in Taiwan with newly diagnosed herpes zoster had 1.49 times the 
rate of developing major depression, compared with controls. Given 
that herpes zoster may be linked to depression via both immune-
related mechanisms as well as adverse psychological effects related 
to neuralgia, it is possible that had data on occurrence of herpes zos-
ter been available in the present study, we would have also detected 
an association between VZV and depression among those experienc-
ing this condition.
Studies examining the association between T gondii and depres-
sion have also yielded mixed results (12,14,41). For example, Groër 
and colleagues found among a small cohort of pregnant women that 
among those seropositive for T gondii, IgG antibody titer was posi-
tively correlated with higher depressive symptoms assessed via the 
Table 2. Association Between Pathogen Seropositivity and Immunoglobulin G Antibody Level, Interleukin-6 and C-Reactive Protein Levels 
at Baseline and Incident Depression Among Individuals in the Sacramento Area Latino Study on Aging
(N=771)
Odds Ratio (95% Confidence Interval)
Model 1a Model 2b Model 3c Model 4d Model 5e
Pathogens
Serostatus
Herpes simplex virus-1 1.25 (0.91, 1.72) 1.26 (0.91, 1.74) 1.31 (0.94, 1.81) 1.32 (0.95, 1.84) 1.32 (0.95, 1.84)
  Cytomegalovirus 1.58 (1.15, 2.16)* 1.39 (1.01, 1.91)* 1.38 (1.00, 1.90)* 1.36 (0.98, 1.88) 1.38 (1.00, 1.90)*
Varicella zoster virus 0.97 (0.77, 1.21) 1.01 (0.80, 1.28) 1.00 (0.79, 1.27) 1.00 (0.79, 1.27) 1.00 (0.79, 1.27)
  Helicobacter pylori 1.14 (0.78,1.66) 1.11 (0.76, 1.63) 1.07 (0.73, 1.57) 1.07 (0.73, 1.56) 1.06 (0.72, 1.55)
Toxoplasma gondii 1.09 (0.87, 1.36) 1.01 (0.80, 1.28) 1.00 (0.79, 1.27) 1.00 (0.79, 1.26) 1.00 (0.79, 1.27)
IgG Antibody Level 
Herpes simplex virus-1 0.99 (0.89, 1.10) 0.99 (0.89, 1.11) 1.00 (0.90, 1.12) 1.00 (0.89, 1.12) 1.00 (0.90, 1.12)
  Cytomegalovirus 1.14 (1.04, 1.25)* 1.08 (0.98, 1.20) 1.08 (0.97, 1.19) 1.07 (0.96, 1.18) 1.07 (0.97, 1.19)
Varicella zoster virus 0.97 (0.87, 1.08) 1.01 (0.90, 1.12) 1.00 (0.90, 1.11) 1.00 (0.89, 1.11) 1.00 (0.89, 1.11)
  Helicobacter pylori 0.96 (0.87, 1.07) 0.94 (0.84, 1.04) 0.93 (0.84, 1.04) 0.93 (0.84, 1.04) 0.93 (0.84, 1.04)
Toxoplasma gondii 1.03 (0.93, 1.15) 0.99 (0.89, 1.11) 0.98 (0.87, 1.09) 0.97 (0.87, 1.09) 0.98 (0.87, 1.09)
Pro-inflammatory Markers
Log Interleukin-6 1.16 (1.05, 1.28)* 1.12 (1.01, 1.24)* 1.09 (0.98, 1.22) NA NA
Log C-reactive protein 1.09 (0.98, 1.22) 1.06 (0.95, 1.19) 1.03 (0.92, 1.17) NA NA
aModel 1 for pathogen seropositivity/immunoglobulin G antibody level and pro-inflammatory markers unadjusted.
bModel 2 for pathogen seropositivity/immunoglobulin G antibody level and pro-inflammatory markers adjusted for sociodemographic characteristics includ-
ing age, gender, education level (for pathogen seropositivity) or income level (for pathogen IgG antibody level), nativity, level of acculturation and marital status.
cModel 3 for pathogen seropositivity/immunoglobulin G antibody level additionally adjusted for body mass index (kg/m2), smoking status and alcohol use at 
baseline and for pro-inflammatory markers additionally adjusted for these factors as well as use of non-steroidal anti-inflammatory drugs at baseline.
dModel 4 for pathogen seropositivity/immunoglobulin G antibody level additionally adjusted for log interleukin-6 level.
eModel 5 for pathogen seropositivity/immunoglobulin G antibody level additionally adjusted for log C-reactive protein level.
*p < 0.05.
Profile of Mood States (POMS), after controlling for age and sex 
(12). In contrast, Alvarado-Esquivel and colleagues (13) recently 
found no association between T gondii seropositivity and depression 
in a small case–control study of pregnant women in Durango City, 
Mexico. Two other studies carried out in middle-aged population- 
and community-based samples also found no association between 
T gondii seropositivity and depression (14,41). Further studies are 
needed to fully understand the role of T gondii in the etiology of 
depression at different stages of the life course as to our knowledge, 
this is the first study to examine the relationship between this patho-
gen and depression in older individuals.
We are only aware of one other study to date that has examined 
whether there are sex/gender differences in the effect of persistent 
pathogens on depression (15). Simanek and colleagues (15) identi-
fied a positive association between seropositivity for H pylori and 
dysthymia among women (OR: 2.37, 95% CI: 1.07–5.24), but a 
protective effect of CMV and H pylori seropositivity on dysthymia 
and depression among men, and no association between HSV-1 sero-
positivity and any mood disorder outcomes among women or men. 
CMV IgG antibody level was also positively (although not statisti-
cally significantly) associated with mood disorders among women, 
but data were unavailable for men (15). In contrast, in the present 
study, we did not identify an association between H pylori seroposi-
tivity among women or men. Simanek and colleagues (15) hypoth-
esized that variation in the influence of H pylori on the production 
of endocrine hormones linked to depression such as ghrelin may 
serve to explain the differences in the association between H pylori 
and depression that was observed among young- to middle-aged 
U.S.  women and men. Given that ghrelin levels have been shown 
to decline with age (42), it is possible that any differences in the 
association between H pylori and depression attributable to ghrelin 
production, may wane as individuals age. Overall, future studies are 
needed that elucidate whether ghrelin production, as well as other 
pathways, are relevant mechanisms by which H pylori may influ-
ence mood and whether these mechanisms differ between women 
and men across the life course.
The contribution of CMV to alterations to the T-cell compart-
ment of the adaptive immune system may also serve to explain the 
more consistent finding of an association between this pathogen and 
depression across studies as well as the stronger effects observed 
among women. Among individuals who are CMV seropositive, oli-
goclonal expansion of memory cells targeted against this pathogen 
results in a large proportion of terminally differentiated effector T 
cells that are CMV-specific and thus CMV seropositivity has been 
implicated as key driver of aging of the adaptive immune system 
(43). Indeed, Aiello and colleagues recently found among a subset 
of middle-aged individuals in DNHS, that compared with CMV 
seronegative individuals, those who were CMV seropositive had a 
3.80 unit (95% CI: 2.46–5.14) increase in log CD4 effector (CCR7−
CD45RA+CD27−CD28−)/naïve (CCR7+CD45RA+CD27+CD28+) 
(E/N) ratio and a 1.15 unit (95% CI: 0.28–2.02) increase in log CD8 
E/N ratio (44). Similar associations were not, however, detected for 
HSV-1  (data not published). A growing number of studies also sug-
gest that T-cell activation may play an important role in the etiol-
ogy of depression (45), with recent animal-based models pointing 
to mechanisms outside of inflammation such as via depletion of cir-
culating amino acids necessary for tryptophan production through 
the accumulation in activated T cells (46). Taken together, further 
investigation into whether the observed effects of CMV on depres-
sion may be partially explained by the pathogen-specific effects of 
CMV infection on immune cell aging, particularly among women, 
is warranted.
While inflammation has been hypothesized as a key biologic 
mediator linking infection to depression onset, and CMV seroposi-
tivity was statistically significantly positively correlated with log 
IL-6 levels among the total sample (p = .0040) and among women 
(p = .0270), neither CRP or IL-6 levels at baseline were statistically 
significantly associated with incident depression among the total 
sample, or among women. It is possible that, as recently observed in 
the English Longitudinal Study of Aging (47), sustained elevations in 
inflammation over time is a more important predictor of depression 
onset, than levels of CRP or IL-6 measured at a single time point or 
that other proinflammatory markers are more salient indicators of 
depression risk over long periods of follow-up (19). Our findings 
are consistent, however, with several other recent studies that have 
not found evidence to support a mediating role of inflammation in 
the association between herpesviruses or H pylori and depression 
(15,16). Taken together with findings from previous studies, our 
study suggests that pathogens such as CMV may influence the onset 
of depression via mechanisms outside of inflammatory pathways. In 
addition to influencing alterations to the T-cell compartment, CMV 
is neurotropic, and thus may exert direct damage in regions of the 
brain in which morphological changes have been implicated in the 
etiology of depression such as the amygdala and hippocampus (48).
A few limitations to our study should be considered. First, other 
persistent pathogens which have also been hypothesized to play 
an important role in the etiology of depression such as HSV-2 and 
Epstein Barr virus (9,36), were not assessed in SALSA. In addition, 
there is potential selection bias in our sample as compared with the 
total sample free of depression at baseline, individuals included in 
our analyses were statistically significantly younger, more likely to be 
female, to have higher education and income level, to be Mexican-
born, to be less Mexican-oriented, to have lower CESD scores and to 
be less likely to use NSAIDS. While some of these characteristics (ie, 
female gender, being Mexican-born) are associated with increased 
prevalence and worse immune control of persistent pathogens, oth-
ers (ie, higher education and income level) are associated with lower 
prevalence and better immune control of such pathogens. Taken 
together with the fact that individuals included in our analyses had 
lower CESD scores, our results are likely biased toward the null. In 
addition, the proportion of individuals seropositive for VZV was 
relatively low (ie, 30.1%) which may indicate this population is not 
representative of the general U.S. Mexican American population in 
terms of past exposure to this pathogen (49) and that our findings 
for this pathogen should be interpreted with caution. Last, while 
researchers have argued that seronegative individuals should be 
excluded from analyses of IgG antibody level to better differentiate 
effects of elevated immune response from seropositivity, due to lim-
ited sample size, we estimated the association between IgG antibody 
level and depression among the entire analytic sample. In sensitivity 
analyses excluding seronegative individuals, we also found, however, 
no association between IgG level for any pathogen and incident 
depression (data not shown). Despite any study limitations, this is, 
to our knowledge, the largest and first longitudinal study to date to 
examine the association between a wide array of persistent patho-
gens, inflammation and incident depression over several years of fol-
low-up and therefore improves upon previous cross-sectional studies 
in which there is temporal ambiguity regarding the direction of the 
association between such infections and the onset of depression. In 
addition, while the generalizability of our findings is limited to older 
U.S. Latinos, this is the first study to examine these relationships 
among this rapidly growing proportion of the older U.S. population 
and serves to shed light on the role of persistent pathogens as a novel 
risk factor that may explain changes in the epidemiology of depres-
sion among this subgroup of the population later in life.
Conclusions
Our findings suggest that CMV may be associated with onset of 
depression among older individuals in the United States, particularly 
those who identify as Latino and to a greater extent among women 
than men but may act outside of inflammatory pathways to trigger 
onset of this condition. Continued efforts to develop vaccines tar-
geted against herpesviruses such as CMV as well as future clinical 
trials aimed at evaluating the effectiveness of antiviral treatment for 
reducing depressive symptoms, among older individuals seropositive 
for CMV, may therefore be warranted. Moreover, given that prev-
alence of this pathogen has been found to be higher among U.S. 
Latinos (23), targeting of such interventions to older individuals of 
this population subgroup may also serve to prevent the development 
of race/ethnic disparities in depression among older individuals in 
the United States in the coming decades.
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